Brian Mitchell

Cooley advised Decagon, an innovator in artificial intelligence (AI) customer support agents, on its $65 million Series B financing round, bringing its total amount raised to $100 million.

Cooley advised Second Front Systems (2F), a public-benefit software company focused on enabling the delivery of mission-critical software solutions, on the close of its $70 million Series C funding round.

Cooley advised Confluent, a data-streaming platform pioneering a fundamentally new category of data infrastructure that sets data in motion, on its acquisition of WarpStream, an Apache Kafka-compatible data-streaming platform.

Cooley advised NGM Biopharmaceuticals (NGM Bio), a wholly owned subsidiary of NGM Bio Holdings and a privately held biotechnology company focused on discovering and developing transformative therapeutics for patients, on its $122 million Series A financing.

Cooley advised Heartbeat Health, one of the top cardiovascular care companies in the US, on the close of its Series C financing led by Cressey & Company, a private investment firm focused on building leading healthcare services and information technology businesses.